Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CTIC CTI BioPharma Corporation

0.00 (0.0%)
Nov 29 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 10.01
Ask Price 8.64
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
CTI BioPharma Corporation CTIC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 9.09 19:00:00
Open Price Low Price High Price Close Price Prev Close
9.09 9.09
Trades Volume Avg Volume 52 Week Range
0 0 - 4.005 - 9.10
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 9.09 USD

CTI BioPharma Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.20B - - - -1,291.93
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

CTI BioPharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No CTIC Message Board. Create One! See More Posts on CTIC Message Board See More Message Board Posts

Historical CTIC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months9.,438,6470.060.66%
1 Year5.859.104.0056.854,112,2453.2455.38%
3 Years3.689.101.435.192,912,4365.41147.01%
5 Years1.739.100.60014.641,981,2937.36425.43%

CTI BioPharma Description

CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under pipeline include PIXUVRI, and Pacritinib. PIXUVRI is a novel aza-anthracenedione with unique structural and physiochemical properties. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

Your Recent History

Delayed Upgrade Clock